Skip to main content
Figure 2 | BMC Health Services Research

Figure 2

From: The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study

Figure 2

Number of total, inappropriate, and pharmacist-preventable inappropriate IV ciprofloxacin doses. p = 0.0005 for difference in the proportions of inappropriate IV ciprofloxacin doses between phases. p = 0.0026 for difference in the proportions of pharmacist-preventable inappropriate IV ciprofloxacin doses between phases.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us